ProPhase Labs Inc (PRPH)
5.11
+0.06
(+1.19%)
USD |
NASDAQ |
May 28, 16:00
5.11
0.00 (0.00%)
After-Hours: 20:00
ProPhase Labs Cash from Financing (Quarterly): 2.271M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.271M |
December 31, 2023 | 2.924M |
September 30, 2023 | 1.20M |
June 30, 2023 | -0.047M |
March 31, 2023 | 1.68M |
December 31, 2022 | -9.498M |
September 30, 2022 | -3.122M |
June 30, 2022 | -6.181M |
March 31, 2022 | -7.222M |
December 31, 2021 | -0.962M |
September 30, 2021 | 0.00 |
June 30, 2021 | -4.546M |
March 31, 2021 | 40.64M |
December 31, 2020 | 0.066M |
September 30, 2020 | 9.924M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | -2.893M |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | -2.929M |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | -11.36M |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | -3.825M |
September 30, 2017 | -9.192M |
June 30, 2017 | -1.756M |
March 31, 2017 | -1.431M |
December 31, 2016 | -0.10M |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 1.38M |
September 30, 2015 | 1.04M |
June 30, 2015 | 0.524M |
March 31, 2015 | |
December 31, 2014 | -0.099M |
September 30, 2014 | 0.083M |
June 30, 2014 | 3.879M |
March 31, 2014 | 0.947M |
December 31, 2013 | 0.149M |
September 30, 2013 | 0.027M |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.195M |
December 31, 2012 | 1.07M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-9.498M
Minimum
Dec 2022
40.64M
Maximum
Mar 2021
1.211M
Average
--
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
Fonar Corp | -1.761M |
XWELL Inc | 0.00 |
Applied DNA Sciences Inc | 3.015M |
Veracyte Inc | -0.864M |
OncoCyte Corp | 0.00 |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -5.119M |
Cash from Investing (Quarterly) | 2.435M |
Free Cash Flow | -20.52M |
Free Cash Flow Per Share (Quarterly) | -0.3357 |
Free Cash Flow to Equity (Quarterly) | -8.475M |
Free Cash Flow to Firm (Quarterly) | -5.693M |
Free Cash Flow Yield | -22.91% |